Abstract
CO9 A Real-World Examination of HBA1C Reduction and Target Achievement Comparing SGLT2 Inhibitors and GLP1 Receptor Agonists As Second-Line Augmentation to Metformin for Treating Type II Diabetes
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have